Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wei-Hong Cheng
Oral Paclitaxel in the Treatment of Metastatic Breast Cancer (MBC) Patients.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
A Novel Patient-Specific Protein Expression-Based Algorithmic Model for Immune Checkpoint Inhibition Therapy Response Prediction in a Pan-Cancer Cohort
Related publications
The Impacts of Inclusion in Clinical Trials on Outcomes Among Patients With Metastatic Breast Cancer (MBC)
PLoS ONE
Multidisciplinary
2′-Behenoyl-Paclitaxel Conjugate Containing Lipid Nanoparticles for the Treatment of Metastatic Breast Cancer
Cancer Letters
Cancer Research
Oncology
Analysis of Eribulin Mesylate Dosing Modifications Impact on Administration Persistence in Patients With Metastatic Breast Cancer (Mbc)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Treatment of Oral Cancer Using Magnetized Paclitaxel
Oncotarget
Oncology
Prolonged Survival of Patients Receiving Trastuzumab Beyond Disease Progression for HER2 Overexpressing Metastatic Breast Cancer (MBC)
Oncology Research and Treatment
Cancer Research
Oncology
Hematology
Nab-Paclitaxel for the Management of Triple-Negative Metastatic Breast Cancer
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology
Oral Fluoropyrimidines Among the New Drugs for Patients With Metastatic Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Eribulin Mesylate in the Treatment of Metastatic Breast Cancer
Biologics: Targets and Therapy
Oncology
Immunology
Gastroenterology
Pharmacology
Rheumatology
Allergy
Changing Treatment Paradigms in Metastatic Breast Cancer
JAMA Oncology
Cancer Research
Oncology
